| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Molecular and Cellular Biology, July 2008, p. 4300-4309, Vol. 28, No. 13
0270-7306/08/$08.00+0 doi:10.1128/MCB.01855-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Microbiology,1 Department of Obstetrics and Gynecology,4 Interdisciplinary Graduate Program in Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242,5 Laboratory of Molecular Immunology,2 Transgenic Core Facility, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892-16743
Received 11 October 2007/ Returned for modification 21 November 2007/ Accepted 13 April 2008
GA binding protein (GABP) is a ubiquitously expressed Ets family transcription factor that consists of two subunits, GABP
and GABPβ. GABP
binds to DNA, and GABPβ heterodimerizes with GABP
and possesses the ability to transactivate target genes. Our previous studies using GABP
-deficient mice revealed that GABP
is required for the development of both T and B cells. Two splice variants of GABPβ are generated from the Gabpb1 locus and differ in their carboxy-terminal lengths and sequences. The longer isoform (GABPβ1L) can homodimerize and thus form
2β2 tetramers depending on the gene context, whereas the shorter isoform (GABPβ1S) cannot. In this study, we generated mice that are deficient in GABPβ1L but that retain the expression of GABPβ1S. Surprisingly, GABPβ1L–/– mice had normal T- and B-cell development, and mature T and B cells showed normal responses to various stimuli. In contrast, targeting both GABPβ1L and GABPβ1S resulted in early embryonic lethality. Because of its incapability of forming homodimers, GABPβ1S has been suspected to have a dominant negative role in regulating GABP target genes. Our findings argue against such a possibility and rather suggest that GABPβ1S has a critical role in maintaining the transcriptional activity of the GABP
/β complex.
Published ahead of print on 21 April 2008.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|